LEUKOTRIENES AND SENSORY INNERVATION IN BLOOD-AQUEOUS BARRIER DISRUPTION IN THE DOG

被引：15

作者：

WARD, DA

FERGUSON, DC

KASWAN, RL

GREEN, K

机构：

[1] Department of Small Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, Georgia

[2] Department of Physiology and Pharmacology, University of Georgia College of Veterinary Medicine, Athens, Georgia

[3] Department of Physiology, Department of Endocrinology, Medical College of Georgia, Augusta, Georgia

[4] Department of Urban Practice, College of Veterinary Medicine, University of Tennessee, Knoxville

来源：

JOURNAL OF OCULAR PHARMACOLOGY | 1992年 / 8卷 / 01期

关键词：

D O I：

10.1089/jop.1992.8.69

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

The effect of a specific 5-lipoxygenase inhibitor, PF5901 (5% in corn oil), on disruption of the blood-aqueous barrier (BAB) in the dog was investigated using a unilateral mild paracentesis model. BAB breakdown was quantitated using anterior chamber fluorophotometry. Fluorescence in the eyes of the PF5901 group was not statistically significantly different (P>0.05) from that in the vehicle group. A tendency towards greater fluorescein concentrations was noted in the PF5901 treated eyes. It was concluded that leukotrienes are not important mediators of BAB disruption in this model and that leukotriene inhibitors may actually exacerbate disruption due to shunting of arachidonate metabolism towards the cyclooxygenase and/or epoxygenase pathways. In a second experiment, the effects of proparacaine and flurbiprofen were evaluated on blood-aqueous barrier disruption and pupil size following a more severe paracentesis. Flurbiprofen dampened both barrier disruption and the miotic response but proparacaine suppressed neither reaction, suggesting that, in the dog, prostaglandins are more important mediators of the ocular irritative response than are sensory neuropeptides.

引用

页码：69 / 76

页数：8

共 35 条

[1]

Yamauchi H., Iso T., Iwas J., Iwata H., The role of prostaglandins in experimental ocular inflammations, Agents Actions, 9, pp. 280-283, (1979)

[2]

Podos S.M., Becker B., Kass M.A., Prostaglandin synthesis, inhibition, and intraocular pressure, Invest Ophthalmol, 12, pp. 426-433, (1973)

[3]

Whitelocke R.A.F., Eakins K.E., Vascular changes in the anterior uvea of the rabbit produced by prostaglandins, Arch Ophthalmol, 89, pp. 495-499, (1973)

[4]

Beitch B.R., Eakins K.E., The effects of prostaglandins on the intraocular pressure of the rabbit, Br J Pharmacol, 37, pp. 158-167, (1969)

[5]

Wilkie D.A., The background of ocular prostaglandins and their role in ophthalmic physiology and pathology, Trans Am Coll Vet Ophthalmol, 20, pp. 3-19, (1989)

[6]

Stjernschantz J., Bito L.Z., The ocular effects of eicosanoids and other autocoids: Historic background and the need for a broader perspective, The Ocular Effects of Prostaglandins and Other Eicosanoids, pp. 1-13, (1989)

[7]

Chiou L., Chiou G., Ocular anti-inflammatory action of a lipoxygenase inhibitor in the rabbit, J Ocular Pharmacol, 1, pp. 383-389, (1985)

[8]

Dziezyc J., Millichamp N.J., Rohde B.S., Baker J.S., Chiou G.C.Y., Effects of lipoxygenase inhibitors in a model of lensinduced uveitis in dogs, Am J Vet Res, 50, pp. 1877-1882, (1989)

[9]

Rao N.A., Patchett R., Fernadez M.A., Sevanian A., Kunkel S.L., Marak G.E., Treatment of experimental granulomatous uveitis by lipoxygenase and cyclooxygenase inhibitors, Arch Ophthalmol, 105, pp. 413-415, (1987)

[10]

Tervo T., Tervo R., Eranko L., Ocular neuropeptides, Med Biol, 60, pp. 53-60, (1982)

← 1 2 3 4 →